Top

Reactions Weekly

Published in:

01-05-2024 | Systemic Lupus Erythematosus | Case report

Pembrolizumab

Systemic lupus erythematosus and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Ceccarelli F, et al. Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: A case report. Rheumatology 60: E39-E40, No. 2, Feb 2021. Available from: URL: https://dx.doi.org/10.1093/rheumatology/keaa389

Title: Pembrolizumab
Systemic lupus erythematosus and lack of efficacy
Publication date: 01-05-2024
Publisher: Springer International Publishing
Keywords: Systemic Lupus Erythematosus
Prednisolone
Rheumatoid Arthritis
Alopecia Areata
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-58468-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Systemic lupus erythematosus and lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Prednisolone

Mirtazapine

Tozinameran

Inclisiran/pantoprazole

Non-serious case reports

Taliglucerase-alfa